Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/24 17:33 | 11/11/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.d | -20 | 7.82 | 0 | -3 | -2 | 121 | D | ||||||||||||||
10/15/24 13:45 | 10/10/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.d | -40 | 8.10 | 0 | -5 | -4 | 121 | D | ||||||||||||||
9/11/24 17:17 | 9/10/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.d | -53 | 10.65 | 0 | -5 | -4 | 121 | D | ||||||||||||||
8/13/24 18:34 | 8/12/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.d | -58 | 11.53 | 0 | -5 | -4 | 121 | D | ||||||||||||||
7/12/24 16:55 | 7/10/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.dm | -923 | 16.79 | 0 | -55 | -31 | 121 | D | ||||||||||||||
6/12/24 17:00 | 6/10/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.d | -88 | 17.65 | 0 | -5 | -3 | 171 | D | ||||||||||||||
5/14/24 16:04 | 5/13/24 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | S.d | -66 | 13.22 | 0 | -5 | -3 | 171 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |